[Obesity: one of this century's greatest health challenge?].
The prevalence of overweight and obesity exceed 50% in many European countries. Obesity is responsible for 2-8% of all health costs and 10-13% of all deaths in Europe. Only a fraction of patients obtain a medically relevant weight loss of 5-10% through lifestyle intervention. Surgery is limited to severe obesity and is very costly; therefore pharmaceuticals are a relevant alternative. Such treatment is hampered by the lack of official guidelines and a relatively limited effect compared to the expectations of patients as well as medical staff. Guidelines and official subsidies are debated.
Københavns Universitet, Det Biomedicinske Fakultet, Institut for Human Ernaering, og Reduce - en forskningsklinik, og Gentofte Hospital, Klinisk Ernaeringsenhed, Denmark. st@reduce.dk
Søren
S
Toubro
Arne V
AV
Astrup
D000328:Adult; D019440:Anti-Obesity Agents / Q000627:therapeutic use; D050110:Bariatric Surgery; D003718:Denmark / Q000453:epidemiology; D005060:Europe / Q000453:epidemiology; D005260:Female; D014943:Global Health; D017048:Health Care Costs; D006801:Humans; D008019:Life Style; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000401:mortality / Q000517:prevention & control* / Q000628:therapy; D015995:Prevalence; D011634:Public Health; D015431:Weight Loss
D019440:Anti-Obesity Agents